Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial - Top-Institutions - MDSpire

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

  • By

  • Filip Ventorp

  • Marie Asp

  • Sofia Olsson

  • Jesper Lindahl

  • Stefan Möller

  • Martina Svensson

  • Filip Ängeby

  • Armida Pravdinske

  • Johanna Tjernberg

  • Susann Schrey

  • Darya Ståhl

  • Viktor Magnusson

  • Emilia Eliasson

  • Anna Agelii-Weber

  • Erika Stålhammar

  • Danielle van Westen

  • Tomas Deierborg

  • Kristoffer N. T. Månsson

  • Diego A. Pizzagalli

  • Åsa Hammar

  • Åsa B. Tornberg

  • Johannes Björkstrand

  • Daniel Lindqvist

  • June 12, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Psychiatry
  • #2

    University of New South Wales
    University of New South Wales

    Sydney, New South Wales

    Key Differentiators

    • Psychiatry

Original Source(s)

Related Content